ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0786

A Machine Learning Approach to Understand Age as a Risk Factor for Complications After Total Hip Arthroplasty

Chloe Heiting1, Yiyuan Wu2, Susan Goodman3, Peter Sculco4, Fei Wang2, Rich Caruana5, Peter Cram6, Said Ibrahim7 and Bella Mehta8, 1Northwell Health, New Hyde Park, NY, 2Weill Cornell Medicine, New York, NY, 3Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, 4Hospital for Special Surgery, New York, NY, 5Microsoft, Redmond, WA, 6University of Maryland School of Medicine, Baltimore, MD, 7Thomas Jefferson University, Philadelphia, PA, 8Hospital for Special Surgery, Weill Cornell Medicine, Jersey City, NJ

Meeting: ACR Convergence 2025

Keywords: Aging, Arthroplasty, Orthopedics, risk assessment, risk factors

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: Abstracts: Orthopedics, Low Back Pain, & Rehabilitation (0783–0788)

Session Type: Abstract Session

Session Time: 1:45PM-2:00PM

Background/Purpose: Utilization of total hip arthroplasty (THA) has grown rapidly in the United States and worldwide. Postoperative complications and patient risk is of great consideration by patients and clinicians. The risk associated with patient-level factors such as age has traditionally been examined using regression models, yet these models lack nuance necessary for detailed risk quantification. We aimed to examine the effect of age as a risk factor for adverse THA outcome through the application of modern machine learning algorithms.

Methods: Patients undergoing THA from 2012-2018 were identified from the Pennsylvania Cost Containment Database using ICD codes and included in the analysis. Patient-level covariates (demographics, discharge location, admission source, insurance, comorbidities) were extracted. Age was examined as a risk factor for the binary outcomes 90-day readmission, 90-day mortality, and 1-year revision as well as the continuous outcome length of stay (LOS) using an explainable boosting machine (EBM). EBMs are a form of generalized additive models characterized by high accuracy and full interpretability, mitigating effects for collinearity and allowing for automatic interaction detection. The predictive performance of the EBM model was described by area under the receiver operating curve (AUROC) for binary outcomes and root mean square error (RMSE) for continuous outcomes. The marginal relationship of age on adverse outcomes was characterized by partial dependency plots.

Results: We analyzed a cohort of 105,336 patients. The median age was 65.0 years, and most patients were White (90.1%), Medicare-insured (51.6%), and discharged home or to health home care (78.1%) (Table 1). The incidence of 90-day readmission was 8.00%, 90-day mortality was 0.29%, and 1-year revision was 1.54%. The EBM prediction model yielded highest prediction for mortality (AUROC=0.80), followed by readmission (0.68), revision (AUROC=0.60), and LOS (RMSE=0.41, R2=0.19). Of the examined patient-level demographics and covariates, age was identified as one of the most important factors in the prediction of each adverse outcome. 90-day mortality risk increased at 79.5 years, and again dramatically at 80.5 years. Conversely, risk of revision decreased at the age of 46.5 years, whereas risk of readmission decreased at 48.5 years but increased at 71.5 years. LOS risk decreased at 52.5 years and increased at 74.5 years (Figure 1).

Conclusion: Despite decreased rates of postoperative complications in THA, age remains a prominent risk factor for consideration in clinical decision making. Modern machine learning analysis demonstrated that the relationship between age and adverse THA outcomes is nonlinear, and risk for each outcome changes drastically at different ages. This finding provides a deeper and more nuanced model compared to logistic regression, which traditionally describe fixed changes in risk with age. This study can support personalized decision-making for patients and physicians in THA.

Supporting image 1Table 1. Patient level characteristics by outcome

Supporting image 2Figure 1. Partial dependency plots illustrating the marginal effect of age (years) on (A) 90-day mortality, (B) 90-day readmission, (C) 1-year revision, and (D) length of stay from the supervised explainable boosting machine models.

Y-axis score in log scale. Vertical lines demonstrate where risk score is equal to 0, and show the average contribution of age to risk.


Disclosures: C. Heiting: None; Y. Wu: None; S. Goodman: Johnson and Johnson, 2, Novartis, 5, Pfizer, 2; P. Sculco: BetterPT, 8, Enovis, 2, 9, HS2, LLC, 8, HSS ASC Development Network, LLC, 8, Intellijoint Surgical, Inc, 8, Joint Effort Administrative Services Organization, 8, Osgenic, 1, 8, Parvizi Surgical Innovation, LLC, 8, Zimmer Biomet, 2, 5, 9; F. Wang: None; R. Caruana: None; P. Cram: None; S. Ibrahim: None; B. Mehta: Amgen, 1, Horizon, 1.

To cite this abstract in AMA style:

Heiting C, Wu Y, Goodman S, Sculco P, Wang F, Caruana R, Cram P, Ibrahim S, Mehta B. A Machine Learning Approach to Understand Age as a Risk Factor for Complications After Total Hip Arthroplasty [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/a-machine-learning-approach-to-understand-age-as-a-risk-factor-for-complications-after-total-hip-arthroplasty/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-machine-learning-approach-to-understand-age-as-a-risk-factor-for-complications-after-total-hip-arthroplasty/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology